The event, sponsored by J.P. Morgan, Numis, Penningtons Manches, PwC and Consilium Strategic Communications, and held in partnership with the MedCity, BioIndustry Association (BIA) and One Nucleus, will highlight the direction of leading technologies and investment for the future. This invitation-only, free to attend conference will showcase leading public and private UK life sciences companies through a series of short presentations and themed panel sessions. Robert Jenrick, MP, will deliver a keynote discussing Government strategies that will impact the healthcare sector. Panels and keynote presentations will tackle issues covering innovation in areas such as lifesciences business models, respiratory therapies and for the first time, digital health. Once again we will play host to host leading industry experts and feature key representatives of AstraZeneca, Syncona, Abcam, Vectura, Circassia, Maxcyte, GSK and many others.
| 08.30 |
Registration |
| 09.00 |
Welcome
- Robert Barnes, Global Head of Primary Markets & CEO Turquoise Global Holdings, London Stock Exchange Plc
|
| 09.05 |
Policy Keynote
- Robert Jenrick MP, The Exchequer Secretary to the Treasury, HMG
|
| 09.25 |
Markets Keynote
- James Mitford, Managing Director, JP Morgan
|
| 09.35 |
Industry Keynote - Future Innovations in Respiratory Healthcare
- Dave Allen, Head of Respiratory Therapy, GSK
|
| 09.55 |
Panel I – Investing in Innovation
- Martin Murphy, CEO, Syncona
- David Baynes, COO, IP Group
- Victor Christou, CEO, CIC
- Vishal Gulati, Partner, Draper Esprit
Chair: James Black, Numis
|
| 10.35 |
Info Shot - Reinventing the scientific method
- Jackie Hunter, CEO, Benevolent.ai
|
| 10.50 |
Coffee Break
|
| 11.20 |
Panel II – Finding Balance
- John Burt, CEO, Abzena
- Doug Doerfler, CEO, Maxcyte
- Shaun Chilton, CEO, Clinigen
- Sarah Howell, CEO, Arecor
Chair: Jo Pisani, Partner, PwC
|
| 12.00 |
Info Shot - Realising the potential of population data
- Joanne Hackett, Chief Commerical Officer, Genomics England
|
| 12.15 |
Panel III – Breath of Fresh Air
- James Ward-Lilly, Group CEO, Vectura
- Steve Harris, CEO, Circassia
- Keyvan Djamarani, Managing Director, Bespak, Consort
- Tom Keith-Roach, Vice President, Respiratory, AstraZeneca
Chair: Chris Shelley, Partner, Penningtons Manches
|
| 12.45 |
Closing Keynote - Innovating to stay ahead in rare diseases
- Peter Meeus, Head of Europe, Shire
|
| 13.00 |
Closing remarks
|
| 13.05 |
Closing Thanks
- Steve Bates, CEO, Bioindustry Association
|
|
13.10
|
Lunch |
